Clinical outcome of Crohn's disease according to the Vienna classification: Disease location is a useful predictor of disease course

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 3, 2006, Pages 255-261

  Oostenbrug, Liekele E ^a   Van Dullemen, Hendrik M ^a   Te Meerman, Gerard J ^a   Jansen, Peter L M ^b   Kleibeuker, Jan H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CARD15; Crohn's disease; Genetic predisposition; NOD2; Vienna classification

Indexed keywords

AZATHIOPRINE;

ADULT; ARTICLE; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DATA ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; ILEUM DISEASE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PARAMETER; PATIENT; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANAL CANAL; ANTIBODIES, MONOCLONAL; CHILD; COLON; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEUM; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL PERFORATION; MALE; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN B 12 DEFICIENCY;

EID: 33644584047     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200603000-00005     Document Type: Article

References (27)

1. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39:690-697.
2. Calkins BM, Mendeloff AI. Epidemiology of inflammatory bowel disease. Epidemiol Rev 1986; 8:60-91.
3. Loftus EV Jr., Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002; 16:51-60.
4. Wolters FL, Russel MG, Stockbrugger RW. Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther 2004; 20:483-496.
5. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997; 92 (suppl 12):5S-11S.
6. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6:8-15.
7. Freeman HJ. Application of the Vienna classification for Crohn's disease to a single clinician database of 877 patients. Can J Gastroenterol 2001; 15:89-93.
8. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49:777-782.
9. Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 2001; 7:306-313.
10. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603.
11. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-606.
12. Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003; 9:281-289.
13. Esters N, Pierik M, van SK, Vermeire S, Claessens G, Joossens S, et al. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol 2004; 99:299-305.
14. Helio T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52:558-562.
15. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70:845-857.
16. Mendoza JL, Murillo LS, Fernandez L, Pena AS, Lana R, Urcelay E, et al. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease. Scand J Gastroenterol 2003; 38:1235-1240.
17. Zankel E, Rogler G, Andus T, Reng CM, Scholmerich J, Timmer A. Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohort. Eur J Gastroenterol Hepatol 2005; 17:395-401.
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170:2-6.
19. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992; 27: 609-614.
20. Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111:580-586.
21. Sachar DB, Bodian CA, Goldstein ES, Present DH, Bayless TM, Picco M, et al. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol 2005; 100:1547-1549.
22. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19(suppl A):5-36.
23. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996; 156:1097-1100.
24. Bayat M, Brynskov J, ge-Petersen H, Hippe E, Lonborg-Jensen H. Direct and quantitative vitamin B12 absorption measurement in patients with disorders in the distal part of the bowel. Comparison of stool spot test (SST) with whole body counting in patients with ileal pelvic reservoir, ileostomy or Crohn's disease. Int J Colorectal Dis 1994; 9:68-72.
25. Lambert D, Benhayoun S, Adjalla C, Gelot MA, Renkes P, Felden F, et al. Crohn's disease and vitamin B12 metabolism. Dig Dis Sci 1996; 41: 1417-1422.
26. Kirschner BS. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. Gastroenterology 1998; 115:813-821.
27. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111:641-649.